F(ab′)2 molecules made from Escherichia coli produced Fab′ with hinge sequences conferring increased serum survival in an animal model
- 1 August 1998
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 217 (1-2) , 1-10
- https://doi.org/10.1016/s0022-1759(98)00061-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Intrachain disulfide bond in the core hinge region of human IgG4Protein Science, 1997
- Preparation and purification of antibody-enzyme conjugates for therapeutic applicationsAdvanced Drug Delivery Reviews, 1996
- Inverted Fab2s (IFab2s): Engineering and expression of novel, dimeric molecules, with a molecular weight of 100 000Molecular Immunology, 1996
- Section Review Biologicals & Immunologicals: Advances in antibody engineeringExpert Opinion on Therapeutic Patents, 1996
- Comparison of the antiplatelet agent potential of the whole molecule, F(ab)2 and fab fragments of humanized anti-GPIIb/IIIa monoclonal antibody in monkeysGeneral Pharmacology: The Vascular System, 1996
- A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibodyMolecular Immunology, 1993
- Mono‐ and Bivalent Antibody Fragments Produced in Escherichia coli: Engineering, Folding and Antigen BindingImmunological Reviews, 1992
- The three-dimensional structure of an intact monoclonal antibody for canine lymphomaNature, 1992
- Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivoInternational Journal of Cancer, 1992
- Site-specific attachment to recombinant antibodies via introduced surface cysteine residuesProtein Engineering, Design and Selection, 1990